OSH6 Antibody

What is OSH6 and what experimental systems are appropriate for studying it?

OSH6 is a lipid transfer protein (LTP) that, together with its paralog OSH7, transports phosphatidylserine (PS) from the endoplasmic reticulum (ER) to the plasma membrane (PM) in yeast. High PS levels at the PM are essential for many cellular functions, including recruitment of signaling proteins, establishment of cell polarity, and initiation of endocytosis . Unlike many other LTPs, OSH6 lacks membrane-targeting motifs yet localizes to ER-PM contact sites through interaction with the ER-PM tether Ist2, a homologue of TMEM16 proteins .

Recommended experimental systems:

• S. cerevisiae is the primary model organism

• Fluorescently tagged OSH6 constructs for localization studies

• Purified recombinant OSH6 for in vitro lipid transfer assays

How should researchers validate OSH6 antibody specificity?

Methodological approach:

• Western blot analysis comparing wild-type vs. osh6Δ yeast strains

• Immunoprecipitation followed by mass spectrometry verification

• Competitive binding assays with purified OSH6 protein

• Cross-reactivity testing against OSH7 (closest paralog)

Validation table:

What are the optimal fixation and permeabilization methods for OSH6 immunostaining?

When detecting OSH6 at membrane contact sites, preservation of membrane structure is critical. Based on research methods used to study OSH6 localization, the following approach is recommended:

• Fix cells with 4% paraformaldehyde for 15-20 minutes at room temperature

• Permeabilize with 0.1% Triton X-100 for 5 minutes (avoid harsher detergents)

• Block with 2% BSA in PBS for at least 30 minutes

• Include 0.1% saponin in antibody dilution buffers to maintain membrane permeabilization

Critical considerations: Since OSH6 localization to ER-PM contacts depends on its interaction with Ist2, harsh fixation or permeabilization can disrupt this interaction and lead to misinterpretation of localization patterns .

How can researchers optimize co-immunoprecipitation protocols for studying OSH6 interactions?

Studies have shown that OSH6 interacts with Ist2, and this interaction is crucial for its localization and function . When designing co-immunoprecipitation experiments:

• Use a gentle lysis buffer (e.g., 20 mM HEPES pH 7.4, 150 mM NaCl, 1% CHAPS or 0.5% NP-40)

• Include phosphatase inhibitors to preserve phosphorylation-dependent interactions (especially important for the Ist2 tail region containing phosphorylated residues T736 and T743)

• Cross-link proteins prior to lysis for transient interactions

• When targeting the Ist2-OSH6 interaction specifically, focus on residues D141 and L142 of OSH6, which comprise part of the Ist2-binding site

Experimental evidence from literature: Pull-down experiments have shown that GFP-Ist2 co-immunoprecipitates with wild-type Osh6-mCherry but not with Osh6(D141A/L142A)-mCherry mutant, confirming the specificity of this interaction .

What approaches resolve discrepancies in OSH6 localization data between different methods?

Researchers often encounter discrepancies when comparing OSH6 localization using different methods. To resolve these:

• Complementary approaches: Combine fluorescently-tagged OSH6 live imaging with immunofluorescence using fixed cells

• Quantitative analysis: Use image analysis software to measure the ratio of cortical to cytosolic OSH6, as demonstrated in literature

• Strain-specific controls: Since OSH6 localization depends on Ist2 expression levels, normalize findings to Ist2 expression

• Mutant analysis: Compare results with known OSH6 mutants (e.g., D141A/L142A) that show altered localization patterns

Methodological guidance from literature:
"Quantification of Osh6-mCherry distribution as a function of GFP-Ist2 or BFP-Ist2 fluorescent signal was performed by profiling cell signal intensity across two transversals line that were manually placed on a single z-section of each cell in the Ist2-fluorescence channel. Ist2 fluorescence was calculated as the mean of four peripheral fluorescence peaks. The same lines were used to measure peripheral fluorescence of Osh6-mCherry in the red channel, divided by the average internal (cytosolic) fluorescence after subtraction of background fluorescence."

How can OSH6 antibodies be used to investigate lipid transfer at membrane contact sites?

Advanced methodological approach:

• Proximity ligation assays (PLA) to detect OSH6-Ist2 interactions in situ

• Super-resolution microscopy combined with immunolabeling to visualize OSH6 at membrane contact sites with nanometer precision

• Correlative light and electron microscopy (CLEM) using OSH6 antibodies to identify contact sites at ultrastructural level

• Lipid extraction assays with immunoprecipitated OSH6 to assess lipid binding capacity

Research findings on OSH6's lipid handling mechanism:
OSH6 exchanges PS with PI4P, which is synthesized at the PM and then hydrolyzed at the ER by the PI4P-phosphatase Sac1. This PI4P transport and degradation are required for efficient PS transport in yeast .

Why might OSH6 antibody staining show predominantly cytosolic rather than cortical localization?

This is a common issue that can have several causes:

• Ist2 dependency: OSH6 localization to ER-PM contacts depends entirely on Ist2. In ist2Δ cells, OSH6 is completely cytosolic . Check Ist2 expression in your experimental system.

• Expression level effects: The ratio between cortical and soluble OSH6 depends on the level of expression of Ist2 . Overexpressing OSH6 relative to Ist2 will result in more cytosolic signal.

• Fixation artifacts: Membrane contact sites are sensitive to fixation methods. The OSH6-Ist2 interaction may be disrupted during sample preparation.

• Critical residues affected: Mutations in the OSH6 Ist2-binding surface (e.g., D141A/L142A) or in the Ist2 tail (especially T736 and T743) disrupt the interaction .

Quantitative relationship data:
Research has established a direct correlation between Ist2 expression levels and OSH6 cortical localization. Plotting the ratio of cortical to cytosolic Osh6 signal as a function of total Ist2 signal shows a clear dependency .

How to distinguish between specific and non-specific binding in OSH6 antibody applications?

Methodological solutions:

• Genetic controls: Include osh6Δ samples to establish baseline non-specific binding

• Peptide competition: Pre-incubate antibody with purified OSH6 protein or specific peptide epitopes

• Parallel antibodies: Use multiple antibodies targeting different OSH6 epitopes

• Quantitative analysis: When using fluorescence microscopy, quantify signal-to-background ratios by measuring fluorescence intensity across cell transects, as described in the literature

How can OSH6 antibodies help investigate the relationship between lipid trafficking and cellular aging?

Recent research has revealed a connection between OSH6 and cellular longevity. Up-regulation of OSH6 boosts an anti-aging membrane trafficking pathway toward vacuoles . Researchers can use OSH6 antibodies to:

• Track changes in OSH6 expression and localization during cellular aging

• Identify age-related post-translational modifications of OSH6

• Investigate OSH6-dependent trafficking pathways affected during aging

Research findings:

• Up-regulation of OSH6 speeds up vesicle trafficking between the trans-Golgi network (TGN) and late endosomes (LE) by adjusting local concentrations of PI4P and PS on the TGN

• OSH6 genetically interacts with DRS2, whose protein works on the Golgi and leads to fragmented vacuoles when mutated

• Over-expression of OSH6 significantly promotes vacuole fusion in drs2Δ cells

What methodological approaches can resolve conflicting data about OSH6 and its paralog OSH7?

Despite their high sequence similarity, OSH6 and OSH7 show different phenotypes when overexpressed:

• Over-expression of OSH6 by a galactose promoter marginally assists the growth of drs2Δ cells

• Over-expression of OSH7 severely delays cell growth at 30°C

• Over-expression of OSH6 significantly promotes vacuole fusion in drs2Δ while OSH7 only marginally affects morphology

Methodological solutions to distinguish between the paralogs:

• Paralog-specific antibodies: Use antibodies targeting non-conserved regions

• Knockout comparisons: Compare osh6Δ, osh7Δ, and double knockout phenotypes

• Domain swapping experiments: Create chimeric proteins to identify functional domains

• Quantitative proteomics: Use antibodies to immunoprecipitate specific complexes for comparison

What are the optimal conditions for immunoprecipitating OSH6 for protein interaction studies?

Based on published research methods, the following protocol is recommended:

• Cell lysis: Use a mild detergent buffer (e.g., 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100)

• Antibody coupling: Couple anti-OSH6 antibodies to Protein A/G beads; consider using crosslinkers to prevent antibody leaching

• Binding conditions: Incubate lysates with antibody-coupled beads for 4 hours at 4°C

• Washing stringency: Use progressive washing with increasing salt concentrations (150-300 mM) to reduce non-specific binding while maintaining physiologically relevant interactions

• Elution method: Competitive elution with OSH6 peptide is preferable to harsh denaturing conditions, especially when studying lipid binding

Experimental evidence:
Successful co-immunoprecipitation of Osh6-mCherry with GFP-Ist2 has been documented, demonstrating the feasibility of this approach for studying OSH6 interactions .

How to quantitatively assess OSH6-dependent lipid transport using antibody-based techniques?

Multi-method approach:

• Lipid transfer assays: Use purified OSH6 (immunoprecipitated with validated antibodies) in in vitro assays with fluorescent lipid analogs

• Subcellular fractionation with immunoblotting: Isolate membrane fractions and detect OSH6 levels in different compartments using quantitative western blotting

• Proximity labeling: Use OSH6 antibodies conjugated to enzymes like APEX2 or BioID to identify proteins in proximity to OSH6 at contact sites

• Lipid distribution analysis: Use C2Lact-GFP as a PS sensor and quantify its distribution at the plasma membrane vs. internal membranes

Quantification method from literature:
"Steady-state distribution of C2Lact-GFP was analyzed on a single z-section of each cell. Using wand (tracing) tool, the external limit of the cell (perimeter) was selected and total cell fluorescence was measured. Subsequently, internal fluorescence was measured after reducing the cell perimeter. Peripheral fluorescence (difference between total and internal fluorescence) was normalized to total fluorescence and plotted as 'peripheral signal'."